Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Routine Evaluation of Somatostatin Receptor Type 2 in Patients With Acromegaly: Do We Still Need More Evidence? | J Clin Endocrinol Metab | 2022 | 36215656 | PubTator, text mining | PubMed |
| Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021. | J Hematol Oncol | 2022 | 36209184 | PubTator, text mining | PubMed |
| Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy. | Eur J Cancer | 2022 | 36208569 | PubTator, text mining | PubMed |
| Combined anti-tumor efficacy of somatostatin fusion protein and vaccinia virus on tumor cells with high expression of somatostatin receptors. | Sci Rep | 2022 | 36207478 | PubTator, text mining | PubMed |
| Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment. | Hepat Med | 2022 | 36200122 | PubTator, text mining | PubMed |
| Association of Pathology Markers with Somatostatin Analogue Responsiveness in Acromegaly. | Int J Endocrinol | 2022 | 36199813 | PubTator, text mining | PubMed |
| Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease. | Clin Transl Immunology | 2022 | 36188122 | PubTator, text mining | PubMed |
| Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update. | World J Clin Cases | 2022 | 36186187 | PubTator, text mining | PubMed |
| Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors. | Theranostics | 2022 | 36185603 | PubTator, text mining | PubMed |
| Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report. | Front Oncol | 2022 | 36185251 | PubTator, text mining | PubMed |
| Prostate-Specific Membrane Antigen Expression in Meningioma: A Promising Theranostic Target. | J Neuropathol Exp Neurol | 2022 | 36179256 | PubTator, text mining | PubMed |
| Molecular diagnosis and treatment of meningiomas: an expert consensus (2022). | Chin Med J (Engl) | 2022 | 36179152 | PubTator, text mining | PubMed |
| High-Contrast Detection of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery. | Mol Pharm | 2022 | 36174110 | PubTator, text mining | PubMed |
| Anesthetic Management of Gastrointestinal Carcinoid Tumors: A Case Report. | AANA J | 2022 | 36173796 | PubTator, text mining | PubMed |
| Pasireotide treatment in Cushing's disease: A single tertiary center's experience. | Turk J Med Sci | 2022 | 36161631 | PubTator, text mining | PubMed |
| Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome. | Front Neurosci | 2022 | 36161168 | PubTator, text mining | PubMed |
| Altered expression of somatostatin signaling molecules and clock genes in the hippocampus of subjects with substance use disorder. | Front Neurosci | 2022 | 36161151 | PubTator, text mining | PubMed |
| Case report and literature review: Treatment of multiple meningiomas combined with multiple unruptured aneurysms in a single operation. | Front Surg | 2022 | 36157430 | PubTator, text mining | PubMed |
| Applying a clinical lens to animal models of CAR-T cell therapies. | Mol Ther Methods Clin Dev | 2022 | 36156878 | PubTator, text mining | PubMed |
| New Biology of Pheochromocytoma and Paraganglioma. | Endocr Pract | 2022 | 36150627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=44